Stock data
Filana Therapeutics, Inc. (FLNA)
Filana Therapeutics, Inc. (FLNA) reported net income of -US$90.97M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | — | — | -US$95.39M | -US$90.97M | — |
| 2024 | — | — | -US$141.45M | -US$24.34M | — |
| 2023 | — | — | -US$105.96M | -US$97.22M | — |
| 2022 | — | — | -US$80.02M | -US$76.25M | — |
| 2021 | — | — | -US$32.87M | -US$32.38M | — |
Quarterly results
Data as of 2026-03-31
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-03-31 | — | -US$10.33M | — |
| 2025-12-31 | — | -US$12.54M | — |
| 2025-09-30 | — | -US$10.81M | — |
| 2025-06-30 | — | -US$44.22M | — |
| 2025-03-31 | — | -US$23.40M | — |
| 2024-12-31 | — | -US$27.60M | — |
| 2024-09-30 | — | -US$27.94M | — |
| 2024-06-30 | — | US$6.16M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.